Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 4
2017 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.
Caldeira D, Rodrigues FB, Duarte MM, Sterrantino C, Barra M, Gonçalves N, Pinto FJ, Ferreira JJ, Costa J. Caldeira D, et al. Among authors: sterrantino c. Drug Saf. 2018 Jan;41(1):77-86. doi: 10.1007/s40264-017-0586-2. Drug Saf. 2018. PMID: 28786035 Review.
Letter to the editor.
Sterrantino C, Miroddi M, Phillips B, Stewart L. Sterrantino C, et al. Int J Cancer. 2016 Jun 1;138(11):2763-70. doi: 10.1002/ijc.30005. Epub 2016 Feb 21. Int J Cancer. 2016. PMID: 26789636 Free article. No abstract available.
Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials.
Miroddi M, Sterrantino C, Simonelli I, Ciminata G, Phillips RS, Calapai G. Miroddi M, et al. Among authors: sterrantino c. Crit Rev Oncol Hematol. 2015 Nov;96(2):355-71. doi: 10.1016/j.critrevonc.2015.06.004. Epub 2015 Jun 24. Crit Rev Oncol Hematol. 2015. PMID: 26160607 Review.
Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab).
Miroddi M, Sterrantino C, Simmonds M, Caridi L, Calapai G, Phillips RS, Stewart LA. Miroddi M, et al. Among authors: sterrantino c. Int J Cancer. 2016 Nov 15;139(10):2370-80. doi: 10.1002/ijc.30280. Epub 2016 Jul 28. Int J Cancer. 2016. PMID: 27450994 Free article. Review.
Burden of community-acquired pneumonia in Italian general practice.
Sterrantino C, Trifirò G, Lapi F, Pasqua A, Mazzaglia G, Piccinni C, Cricelli C, Rossi A, Blasi F. Sterrantino C, et al. Eur Respir J. 2013 Dec;42(6):1739-42. doi: 10.1183/09031936.00128713. Epub 2013 Aug 15. Eur Respir J. 2013. PMID: 23949958 Free article. No abstract available.
The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
Squadrito F, Bitto A, Altavilla D, Arcoraci V, De Caridi G, De Feo ME, Corrao S, Pallio G, Sterrantino C, Minutoli L, Saitta A, Vaccaro M, Cucinotta D. Squadrito F, et al. Among authors: sterrantino c. J Clin Endocrinol Metab. 2014 May;99(5):E746-53. doi: 10.1210/jc.2013-3569. Epub 2014 Jan 31. J Clin Endocrinol Metab. 2014. PMID: 24483158 Clinical Trial.